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region for European countries and gender, age, race, and
region for the United States. Participants report if they
have been diagnosed with 5 mental and 12 physical health
conditions. Mental and physical health status is deﬁned
by the SF-8. Non-adherent attitudes are deﬁned by using
three attitudinal statements: use of another’s prescription,
frequent switching, and frequent missed doses. Respon-
dents report their degree of agreement on a ﬁve-point
scale. RESULTS: Overall, France has the highest per-
centage of people with non-adherent attitudes (18% use
another’s prescription; 3% frequently switch; 13% fre-
quently miss doses), and Great Britain has the lowest (8%
use another’s prescription; 2% frequently switch; 9% fre-
quently miss doses). People in all countries with non-
adherent attitudes are more likely to be younger and
less-educated. In Germany and Great Britain, those with
non-adherent attitudes are more likely to be male, and in
France and the US are more likely to be female. For all
countries, mental health is worse among those with non-
adherent attitudes. Physical health is worse among those
with non-adherent attitudes in Great Britain and the US,
but is the same or better in Germany and France. Respon-
dents with a mental health condition in Great Britain and
the United States are more likely to have non-adherent
attitudes. Results varied for France and Germany by 
speciﬁc mental health condition. CONCLUSION: Non-
adherent attitudes vary across countries. These differ-
ences should be considered in creating programs that
promote adherence.
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OBJECTIVES: Osteoporosis therapy places extensive
behavioral demands on patients, including the need for
precisely scheduled daily or weekly medication intake,
regular physical exercise and frequent visits to health care
providers. Although effective treatments are available,
compliance with osteoporosis therapy is known to be low.
It has previously been demonstrated that medication non-
compliance in actual practice—deﬁned as taking less than
80% of prescribed medications—signiﬁcantly increases
the risk of fractures. The objective of this study was 
to explore the effect of varying the deﬁnition of non-
compliance to identify the minimum level of compliance
required to reduce fracture risk. METHODS: Demo-
graphic, prescription drug use, physician services and
hospitalization information for women with osteoporosis
who were dispensed an osteoporosis medication between
1996 and 2001 was obtained from the Saskatchewan
Health data ﬁles. Fractures were identiﬁed by hospital-
ization or physician visits with a relevant diagnostic or
procedure code. Different levels of compliance were
deﬁned based on the proportion of time during which
patients had drugs available: <50% (poor), 50–80%
(medium), 80–90% (good), and >90% (excellent). A Cox
proportional hazards model was used to assess the effect
of compliance, deﬁned as a time-dependent covariate,
controlling for other known risk factors for fractures.
Patients were studied for up to three years following the
index prescription. RESULTS: Among 11,249 women
suffering from osteoporosis the overall fracture rate was
4.8 fractures per 100 person-years. Poor compliance led
to a 40% increase in fracture risk (95% CI: 19%–66%)
compared to excellent compliance, while medium com-
pliance increased risk by 20% (95% CI: 0%–43%). No
statistically signiﬁcant differences in fracture risk were
observed, however, between good and excellent com-
pliance. CONCLUSION: A high level of compliance
(80%–100%) is required to reduce osteoporosis-related
fracture risk.
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OBJECTIVES: 1) To determine if reﬁll-based measures 
of non-adherence could be constructed using claims data;
2) compare and contrast three different compliance 
measures; and 3) determine the degree to which each 
measure predicted hospitalization or emergency room 
events among Medicaid patients with schizophrenia.
METHODS: Retrospective case control study using Med-
icaid claims data. Subjects were 1426 patients with a
diagnosis of schizophrenia who had received at least one
Rx for an antipsychotic medication. Cases were patients
with an event; controls were randomly selected during the
same calendar quarter. Both were continuously eligible
and receiving ambulatory care for at least six months
before the index date. Demographic, medical care use,
comorbidity, and antipsychotic drug usage data were col-
lected. A “days out of therapy” measure, and 2 medica-
tion possession ratio (MPR) scores were computed from
dispensed prescription (Rx) records during the 120-day
window prior to the index event date. RESULTS: Days’
supply was missing or inaccurate for 5.2% of all Rx; and
12.5% of patients had at least one Rx with a missing
days’ supply. Days’ supply could be imputed for most
missing records using a simple algorithm. Two of the 3
compliance measures correlated with each other at r = .33
or higher. The two MPR measures demonstrated low sen-
sitivity for an event (<32%) but relatively high speciﬁcity
(>70%) regardless of cutoff level. The days out measure
demonstrated high sensitivity and low speciﬁcity. An
exploratory model predicting events was developed using
